Arcturus Therapeutics Holdings Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 23.11, 35.29, 42.27, 69.41, 86.25 ], "ebit_estimate": [ -118.85, -134.55, -121.91, -103.39, -77.94 ], "ebitda_estimate": [ -114.22, -124.09, -119.82, null, null ], "net_income_estimate": [ -111.87, -128.48, -112.08, -96.87, -69.93 ], "per_share_eps_estimate": [ -3.9, -4.08, -3.64, -3.03, -2.22 ], "eps_nri_estimate": [ -3.92, -4.02, -3.55, -3.01, -2.2 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null ], "pretax_income_estimate": [ -118.72, -128.48, -111.91, -96.87, -71.46 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ -71.34, -78.63, -43.41, null, null ], "gross_margin_estimate": [ 85, 85, 44, 46.5, 13 ], "operating_cash_flow_estimate": [ null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0 ], "long_term_growth_rate_mean": -12.77, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": -13.8, "future_eps_nri_estimate_growth": -12.77, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": -16.55, "future_ebitda_estimate_growth": -16.88, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -18.97, "future_pretax_income_estimate_growth": -18.21, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 3.13, 7.87, 9.98, 4.37, 2.47, 12.68, 26.01 ], "ebit_estimate": [ -30.8, -27.82, -31.01, -42.22, -45.12, -41.33, -24.47 ], "ebitda_estimate": [ -30.14, -31.57, -33.06, null, null, null, null ], "net_income_estimate": [ -29.23, -25.73, -27.65, -33.01, -35.31, -28.53, -15.85 ], "per_share_eps_estimate": [ -1.03, -0.89, -1, -1, -1.05, -0.87, -0.61 ], "eps_nri_estimate": [ -1.03, -0.91, -1.01, -1, -1.05, -0.87, -0.61 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -29.12, -25.95, -29.16, -40.7, -43.59, -39.8, -22.95 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ -63.59, -77.91, -98.91, null, null, null, null ], "gross_margin_estimate": [ 80, 80, 80, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": -12.77, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": -13.8, "future_eps_nri_estimate_growth": -12.77, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": -16.55, "future_ebitda_estimate_growth": -16.88, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -18.97, "future_pretax_income_estimate_growth": -18.21, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }